| Serum neurofilament light chain levels in healthy individuals: a proposal of cut-off values for use in multiple sclerosis clinical practice P Valentino, F Marnetto, S Martire, S Malucchi, CI Bava, M Popovic, ... Multiple Sclerosis and Related Disorders 54, 103090, 2021 | 14 | 2021 |
| Serum Neurofilaments are a reliable biomarker to early detect PML in Multiple Sclerosis patients P Valentino, S Malucchi, CI Bava, S Martire, M Capobianco, ... Multiple Sclerosis and Related Disorders 77, 104893, 2023 | 3 | 2023 |
| sNFL applicability as additional monitoring tool in natalizumab extended interval dosing regimen for RRMS patients P Valentino, S Malucchi, S Martire, CI Bava, MA Capobianco, A Bertolotto Multiple Sclerosis and Related Disorders 67, 104176, 2022 | 1 | 2022 |
| Comparison between available technologies and biological approaches for CSF and serum NFL quantification: a further step towards implementation in clinical practice C Bava, P Valentino, L Giorgi, S Martire, S Malucchi, A Bertolotto, ... MULTIPLE SCLEROSIS JOURNAL 29, 563-564, 2023 | | 2023 |
| Serum neurofilaments are a reliable biomarker to early detect PML in Multiple Sclerosis patients A Bertolotto, S Malucchi, C Bava, S Martire, M Capobianco, ... MULTIPLE SCLEROSIS JOURNAL 29, 306-307, 2023 | | 2023 |
| Applicability of sNFL in Multiple Sclerosis as Additional Measure to Monitor Treatments in Clinical Practice and Implications in NEDA-3 Evaluation (S19. 001) S Malucchi, P Valentino, F Marnetto, C Bava, S Martire, A Bertolotto, ... Neurology 98 (18 Supplement), 2022 | | 2022 |
| Normal serum NFL levels: a proposal of cut-off strategy definition for the clinical practice P Valentino, F Marnetto, S Martire, C Bava, M Popovic, A Bertolotto MULTIPLE SCLEROSIS JOURNAL 26 (3_ SUPPL), 85-85, 2020 | | 2020 |
| Real-life experience with sNFL in multiple sclerosis patients, as monitoring and treatment decision biomarker P Valentino, F Marnetto, C Bava, S Martire, A Bertolotto MULTIPLE SCLEROSIS JOURNAL 26 (3_ SUPPL), 85-86, 2020 | | 2020 |
